News and updates for Opal Therapeutics and research into reproductive health
-
Spark & Build: Women’s Health Startup Sprint
September 17th, 2025
Interested in building a women’s health company in one night? Join Opal therapeutics on Oct. 6th for our SF TechWeek event! -
Opal Therapeutics joins the CLS FAST 2025 Cohort!
September 10, 2025
Opal Therapeutics is joining the CLS FAST 2025 Accelerator Program to help fast-track innovation in women’s health through organoid-based drug discovery. -
Women's Health 2.0: Beyond Fertility
August 14, 2025
The VC firm, NFX, highlight’s Opal Therapeutic’s organoid biobank for reproductive cells and improving drug discovery and discusses what’s next women’s health. -
Aspen Health Fellows Spotlight: Morgan Stanton
June 13, 2025
Aspen Ideas featured Opal CEO, Morgan Stanton, and her work on uterine organoids to improve reproductive health -
Opal participates in the NSF I-CORPs program
May 8th, 2025
Opal is proud to participate in the NSF I-Corps program to accelerate innovation in women’s health through advanced organoid models -
Opal invited to pitch at MBC Women's Health Forum
April 24th, 2025
MBC Biolabs hosted a Women’s Health Innovation Forum where Opal showcased some of their new work in endometriosis.
-
WPI Journal Cover Story - Opal Therapeutics!
February 6th, 2025
Opal CEO, Morgan Stanton is featured in the WPI Journal and discusses why we need to make major changes in addressing women’s health R&D.
-
Opal Therapeutics arrives at Techstars Demo Day!
December 6th, 2024
All Opal’s hard work has paid off! See CEO, Morgan Stanton, be the first pitch at Techstars San Franciso Demo Day.
-
Opal awarded NSF SBIR Grant
August 22, 2024
Opal is proud to annouce they are the recipient of a Phase I NSF SBIR grant for their research into therapeutic development for women’s health